skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: nido-Dicarbaborate Induces Potent and Selective Inhibition of Cyclooxygenase-2

Journal Article · · ChemMedChem
 [1];  [2];  [1];  [3];  [2];  [2];  [4];  [2];  [1]
  1. Univ. Leipzig (Germany)
  2. Vanderbilt Univ., Nashville, TN (United States)
  3. Univ. Leipzig (Germany); Rheinische Friedrich-Wilhelms-Univ. Bonn (Germany)
  4. Cornell Univ., Ithaca, NY (United States); Argonne National Lab. (ANL), Argonne, IL (United States)

Carbaboranes are increasingly studied as pharmacophores, particularly as replacements for aromatic systems. However, especially ortho–carbaborane is prone to degradation of the cluster, which hampers biological application. This study demonstrates that deboronation of the cluster may not only lead to a more active analogue, but can also improve the solubility and stability of a carbaborane–containing inhibitor. Notably, introduction of a nido–dicarbaborate cluster into the cyclooxygenase (COX) inhibitor indomethacin results in remarkably increased inhibitory potency and selectivity for COX–2 relative to the respective phenyl analogue. The first crystal structure of a carbaborane–containing inhibitor bound to COX–2 further reveals a novel binding mode for the inhibitor that is strikingly different from that of indomethacin. Furthermore, these results indicate that nido–dicarbaborate is a promising pharmacophore that exhibits properties which are also highly beneficial for its introduction into other inhibitor classes.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States)
Sponsoring Organization:
USDOE Office of Science (SC); National Institutes of Health (NIH); National Inst. of General Medical Sciences
Grant/Contract Number:
AC02‐06CH11357; CA89450; P41 GM103403
OSTI ID:
1236266
Journal Information:
ChemMedChem, Vol. 11, Issue 2; ISSN 1860-7179
Publisher:
ChemPubSoc EuropeCopyright Statement
Country of Publication:
United States
Language:
ENGLISH
Citation Metrics:
Cited by: 51 works
Citation information provided by
Web of Science

References (27)

The Role of Chemistry in the Development of Boron Neutron Capture Therapy of Cancer journal July 1993
Die Rolle der Chemie in der Entwicklung einer Krebstherapie durch die Bor-Neutroneneinfangreaktion journal July 1993
The Chemistry of Neutron Capture Therapy journal June 1998
The medicinal chemistry of carboranes journal October 2002
Boron in Drug Discovery: Carboranes as Unique Pharmacophores in Biologically Active Compounds journal September 2011
Carbaboranes as Pharmacophores: Properties, Synthesis, and Application Strategies journal November 2011
Interaction of Carboranes with Biomolecules: Formation of Dihydrogen Bonds journal May 2006
Medicinal Application of Carboranes book October 2011
Novel Boron-Containing, Nonclassical Antifolates:  Synthesis and Preliminary Biological and Structural Evaluation journal July 2007
Carborane-Based Carbonic Anhydrase Inhibitors journal November 2013
Carborane-Based Carbonic Anhydrase Inhibitors journal November 2013
The First CNS-Active Carborane: A Novel P2X 7 Receptor Antagonist with Antidepressant Activity journal April 2014
Preparation and evaluation of carborane-derived inhibitors of prostate specific membrane antigen (PSMA) journal January 2014
Asborin: The Carbaborane Analogue of Aspirin journal May 2009
Synthesis and evaluation of carbaborane derivatives of indomethacin as cyclooxygenase inhibitors journal May 2011
ortho-Carbaborane derivatives of indomethacin as cyclooxygenase (COX)-2 selective inhibitors journal August 2012
2-Carbaborane-3-phenyl-1 H -indoles-Synthesis via McMurry Reaction and Cyclooxygenase (COX) Inhibition Activity journal January 2013
Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition journal August 2004
Structural Approach for COX-2 Inhibition journal August 2004
Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: Facile conversion of nonsteroidal antiinflammatory drugs to potent and highly selective COX-2 inhibitors journal January 2000
Ester and Amide Derivatives of the Nonsteroidal Antiinflammatory Drug, Indomethacin, as Selective Cyclooxygenase-2 Inhibitors journal July 2000
From indomethacin to a selective COX-2 inhibitor: Development of indolalkanoic acids as potent and selective cyclooxygenase-2 inhibitors journal March 1996
Rapid Cage Degradation of 1-Formyl- and 1-Alkyloxycarbonyl-Substituted 1,2-Dicarba- closo -dodecaboranes by Water or Methanol in Polar Organic Solvents journal January 1999
One-pot synthesis of an indole-substituted 7,8-dicarba-nido-dodecahydroundecaborate(−1) journal January 2015
4,5-Diaryloxazole inhibitors of cyclooxygenase-2 (COX-2) journal May 1999
Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents journal December 1996
Structural Basis of Enantioselective Inhibition of Cyclooxygenase-1 by S -α-Substituted Indomethacin Ethanolamides journal July 2007

Cited By (13)

CarbORev-5901: The First Carborane-Based Inhibitor of the 5-Lipoxygenase Pathway journal June 2017
Carborane-Based Analogues of 5-Lipoxygenase Inhibitors Co-inhibit Heat Shock Protein 90 in HCT116 Cells journal December 2018
Isomeric Carborane Neuromuscular Blocking Agents journal April 2019
(N,Se) and (Se,N,Se) Ligands Based on Carborane and Pyridine Fragments - Reactivity of 2,6-[(1′-Me-1′,2′- closo -C 2 B 10 H 10 )SeCH 2 ] 2 C 5 H 3 N towards Copper and Silver: (N,Se) and (Se,N,Se) Ligands Based on Carborane and Pyridine Fragments - Reactivity of 2,6-[(1′-Me-1′,2′-closo-C2B10H10)SeCH2]2C5H3N towards Copper an journal May 2017
Binding of indomethacin methyl ester to cyclooxygenase-2. A computational study journal June 2018
Nanoparticle-based formulation of metallacarboranes with bovine serum albumin for application in cell cultures journal January 2020
Structure–activity relationships for the synthesis of selective cyclooxygenase 2 inhibitors: an overview (2009–2016) journal January 2017
Antiproliferative activity of (η 6 -arene)ruthenacarborane sandwich complexes against HCT116 and MCF7 cell lines journal January 2017
New keys for old locks: carborane-containing drugs as platforms for mechanism-based therapies journal January 2019
Carborane RAFT agents as tunable and functional molecular probes for polymer materials journal January 2019
Half- and mixed-sandwich metallacarboranes for potential applications in medicine journal April 2019
Development of Antioxidant COX-2 Inhibitors as Radioprotective Agents for Radiation Therapy—A Hypothesis-Driven Review journal April 2016
Focus on Chemistry of the 10-Dioxane-nido-7,8-dicarba-undecahydrido Undecaborate Zwitterion; Exceptionally Easy Abstraction of Hydrogen Bridge and Double-Action Pathways Observed in Ring Cleavage Reactions with OH− as Nucleophile journal February 2020